Delfi Diagnostics Inc.
3 clinical trials · Sponsor
◉ Watch Delfi Diagnostics Inc.
| Record | Firm | Date |
|---|---|---|
| Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer (NCT06145750) | Delfi Diagnostics Inc. | 2023-10-31 |
| CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (NCT05306288) | Delfi Diagnostics Inc. | 2022-04-07 |
| DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (NCT04825834) | Delfi Diagnostics Inc. | 2021-03-22 |
Track Delfi Diagnostics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.